Arca Biopharma | ABIO - Trade Creditors


Arca Biopharma reported $4.16M in Trade Creditors for its fiscal quarter ending in December of 2025.





Trade Creditors Change Date
Alterity Therapeutics Limited AUD 1.07M 203.72K Dec/2025
Amgen USD 19.52B 1.37B Mar/2026
Arca Biopharma USD 4.16M 1.95M Dec/2025
Biogen USD 358.5M 73.5M Mar/2026
Brainstorm Cell Therapeutics USD 7.32M 250K Mar/2026
Bristol-Myers Squibb USD 4.23B 659M Mar/2026
Capricor Therapeutics 3.93M 2.27M Mar/2026
Cipla INR 32.3B 1.95B Mar/2026
Clal Biotechnology ILS 21.05M 1.62M Dec/2021
Compugen USD 2.35M 6.77M Dec/2025
CSL USD 3.17B 290M Dec/2025
Cytokinetics USD 24.71M 80.91M Mar/2026
Daiichi Sankyo JPY 568.5B 16.84B Dec/2025
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 1.05B Mar/2026
Grifols EUR 987.75M 47.87M Dec/2025
Laboratory Of America USD 695.7M 145.1M Mar/2026
Myriad Genetics USD 32.6M 2.6M Mar/2026
Otsuka Holdings JPY 196.04B 29.53B Mar/2026
Pfizer USD 4.51B 734M Mar/2026
United Therapeutics USD 498.3M 491.2M Mar/2026